Amgen Inc.

AMGN-Q

NASDAQ:AMGN

258.60
1.50 (0.58%)
Amgen Inc. is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. Located in the Conejo Valley, Amgen is the world's largest independent biotechnology firm.
More at Wikipedia

Analysis and Opinions about AMGN-Q

Signal
Opinion
Expert
PAST TOP PICK
PAST TOP PICK
May 6, 2003
(Was a top pick on Apr 7. Up 7.4%) Still likes.
Show full opinionHide full opinion
(Was a top pick on Apr 7. Up 7.4%) Still likes.
TOP PICK
TOP PICK
April 30, 2003
Three drugs are coming out which are blockbusters.
Show full opinionHide full opinion
Amgen Inc. (AMGN-Q)
April 30, 2003
Three drugs are coming out which are blockbusters.
TOP PICK
TOP PICK
April 7, 2003
Expects the S&P to drop to 820 and this stock could drop. Buy on pull backs. Has three block buster drugs on the way.
Show full opinionHide full opinion
Amgen Inc. (AMGN-Q)
April 7, 2003
Expects the S&P to drop to 820 and this stock could drop. Buy on pull backs. Has three block buster drugs on the way.
BUY WEAKNESS
BUY WEAKNESS
January 13, 2003
Very successful biotech. Big growth. May be a little high.
Show full opinionHide full opinion
Amgen Inc. (AMGN-Q)
January 13, 2003
Very successful biotech. Big growth. May be a little high.
BUY WEAKNESS
BUY WEAKNESS
August 13, 2002
18/20% growth for the next few years. Would prefer to buy in the $30's.
Show full opinionHide full opinion
Amgen Inc. (AMGN-Q)
August 13, 2002
18/20% growth for the next few years. Would prefer to buy in the $30's.
HOLD
HOLD
July 3, 2002
The biotech sector is down. A high quality company.
Show full opinionHide full opinion
Amgen Inc. (AMGN-Q)
July 3, 2002
The biotech sector is down. A high quality company.
DON'T BUY
DON'T BUY
January 2, 2002
Doesn't like their run at Immunex.
Show full opinionHide full opinion
Amgen Inc. (AMGN-Q)
January 2, 2002
Doesn't like their run at Immunex.
BUY WEAKNESS
BUY WEAKNESS
December 28, 2001
A little high now. Would buy at $50.
Show full opinionHide full opinion
Amgen Inc. (AMGN-Q)
December 28, 2001
A little high now. Would buy at $50.
DON'T BUY
DON'T BUY
Amgen Inc. (AMGN-Q)
December 19, 2001
Too expensive.
BUY
BUY
July 31, 2001
A good buy and hold. Good products. Volatile.
Show full opinionHide full opinion
Amgen Inc. (AMGN-Q)
July 31, 2001
A good buy and hold. Good products. Volatile.
BUY
BUY
July 6, 2001
Good broad spectrum. Volatile.
Show full opinionHide full opinion
Amgen Inc. (AMGN-Q)
July 6, 2001
Good broad spectrum. Volatile.
PAST TOP PICK
PAST TOP PICK
June 6, 2001
(Was a top pick on Feb 22/01 down 3%)Still likes. A good entry point. Likes better than Hemasol.
Show full opinionHide full opinion
Amgen Inc. (AMGN-Q)
June 6, 2001
(Was a top pick on Feb 22/01 down 3%)Still likes. A good entry point. Likes better than Hemasol.
TOP PICK
TOP PICK
February 22, 2001
Biotechs should grow substantially. A core company in the biotech sector. Has a pipeline. Profitable.
Show full opinionHide full opinion
Amgen Inc. (AMGN-Q)
February 22, 2001
Biotechs should grow substantially. A core company in the biotech sector. Has a pipeline. Profitable.
BUY WEAKNESS
BUY WEAKNESS
January 8, 2001
Likes. In late stage production
Show full opinionHide full opinion
Amgen Inc. (AMGN-Q)
January 8, 2001
Likes. In late stage production
DON'T BUY
DON'T BUY
October 30, 2000
Facing risks on patents and drugs not that good.
Show full opinionHide full opinion
Amgen Inc. (AMGN-Q)
October 30, 2000
Facing risks on patents and drugs not that good.
Showing 91 to 105 of 105 entries